World Drug Safety Congress Americas

?????? ?????? ????????? Registration is now open for the World Drug Safety Congress Americas, returning to Boston November 4-6 for our 2025 edition ?? In the season of giving, we're excited to offer you a Black Friday exclusive – ????% ?????? your registration for 2025! ??? Use code ?????????????????? at checkout and ???????? $??,?????? your all-access ticket. This deal won't last long – secure your savings today: https://lnkd.in/gSanq3SV FREE passes for pharma & biotech affiliated SMEs, academia, and hospital representatives available here: https://lnkd.in/gcNNXRT3 #WorldDrugSafety #PV #Pharmacovigilance #DrugSafety

?? A Huge Thank You and an Exciting Look Ahead! ?? As we reflect on the incredible experience of the World Drug Safety Congress Americas 2024, held on October 29-30 in Boston, I want to take a moment to express my sincere gratitude to Gina McHugh (Saure) for her outstanding dedication and tireless effort in curating an agenda that brought together over 2,500 global pharmacovigilance professionals. The event was packed with groundbreaking discussions on AI in pharmacovigilance, the latest regulatory updates, and essential insights into medical device safety. Thank you to all the speakers and participants who shared their expertise! ?? Article Preview: Recap of the World Drug Safety Congress Americas 2024 ?? Our latest article delves into the key themes and insights from this extraordinary event. We cover: ???AI & Automation: How advancements are transforming signal detection and data management. ???Regulatory Challenges: Strategies to stay compliant amid evolving international standards. ???Medical Device Safety: The critical need for cybersecurity in an interconnected world. The congress set the stage for innovation and collaboration, offering a glimpse into the future of pharmacovigilance. You can read the full article below. ?? Looking Forward: World Drug Safety Congress Americas 2025 ?? I'm already counting down the days to next year’s event, happening November 4-6, 2025! To make it even more impactful, we want YOUR input: ?? Which topics would you like to learn more about? ?? Who are the experts you'd like to see on stage? Please share your ideas and suggestions in the comments below! Your feedback is invaluable in shaping an agenda that meets the evolving needs of our field. ?? Join the Conversation! Comment, like, and share your thoughts using #WorldDrugSafety2025. And don’t forget to repost and engage with the full article when it goes live! Together, let’s keep the momentum going and drive forward meaningful change in pharmacovigilance practices. Looking forward to hearing your insights! #DrugSafety #Pharmacovigilance #MedicalDevices #RegulatoryAffairs #PatientSafety #WDS2024 #WDS2025

?? It’s a wrap at the World Drug Safety Congress Americas 2024! Whatfix was thrilled to sponsor this event and engage with the pharmacovigilance (PV) community. As PV continues to grow more complex with evolving regulations, increasing caseloads, and global reporting demands, effective post-marketing surveillance has never been more critical. At Whatfix, we’re proud to provide in-app guidance and real-time support for PV systems—helping to reduce tech friction, improve user adoption, enhance compliance, and minimize risks. Together, we’re driving better patient safety outcomes. Missed the event or want to learn more? Feel free to reach out or book a meeting: ?? Book Here https://lnkd.in/gHqeN58H Let’s continue the conversation and make waves in pharmacovigilance together! ?? ?? Learn more: https://lnkd.in/g737JSvD | William Chamblin | Rachita Mehrishi | Darrell Draper | Ayush Dixit | Madhurima Saha | Abhishek Bajpai | Laura Sanchez-Chaparro | Gokul Suresh | Aniket Karapurkar | Harish Babu | Shruti Gautam | Shane Gahlot | Karthik H. | Shruthi Manjunath | Vipul Gupta | Rusheel Nair | #whatfix | #worlddrugsafety | #pharmacovigilance | #innovation | #digitaladoption

???????? ?????? ????????! The World Drug Safety Congress Americas is returning to Boston next spring for our 2025 edition. ??? Boston Convention & Exhibition Center ?? November?4-6, 2025 Get ready and stay tuned... we have plenty of excitement in store for you ?????????soon!??? #WorldDrugSafety #PV #DrugSafety #Pharmacovigilance #GlobalDrugSafety

AI-driven advancements with high value potential are happening across the patient safety ecosystem. Srinivasan Muthusamy and Kirthi Kiran Yadagiri, PhD, shared their insights at the World Drug Safety Congress Americas on the challenges and opportunities of?balancing innovation and compliance for AI technology in a GxP environment. pc: Danielle Abatemarco #worlddrugsafety #wdsc #drugsafety #patientsafety #ai #pharmacovigilance

#AI is the buzzword in the #pharmacovigilance community and it's great to see it's also very popular in the latest issue of #UppsalaReports. At 2024 edition of the World Drug Safety Congress Americas, we had many discussions focused on the role of #automation, #realworldevidence, #ai, #machinelearning as a part of our educational content. Stay tuned for more updates related to how AI is shaping up the #drugsafety activities.

In October, I had the pleasure of supporting friend and colleague Elizabeth Kurian, PharmD as she presented at World Drug Safety Congress Americas. Watching her work in the pharmacovigilance and D.E.I spaces has been inspiring. I’m so proud of her efforts as she continues to bring awareness to the importance of patient centricity and its role in drug safety.

It was great to be back at the World Drug Safety Congress Americas this year, where I had the opportunity to moderate a panel discussion on the applications of artificial intelligence (AI) in real-world evidence (RWE) generation to advance patient safety.??? ? As the healthcare industry continues to evaluate the many ways generative AI and machine learning can improve real-world data (RWD) and effectively and efficiently generate RWE, healthcare companies, including Johnson & Johnson, have made important strides in better understanding this burgeoning field. ? ? During our session, we dove into learnings from these experiences and future opportunities, including:??? ? ?? ???????????????????? ???????????? ????????????????????????????: How the emergence of AI has led to misconceptions and the importance of bringing clarity to what AI can and can’t do in the context of RWE and medical safety.?? ?? ?????????????????? ?????????????????????? ????????????????????: How AI can expedite the review and analysis of RWD and enable faster evidence generation.? ?? ???????????????????? ??????: How companies are using AI to enhance the RWD that are then used to generate reliable RWE.? ? AI has the potential to significantly improve patient care. Reaching that potential will require a dedicated effort to ensure it is being used responsibly, grounded in quality data, and focused on real-world patient needs.? ? My thanks go out to the WDSC Americas organizers and our great group of panelists, including Scott K., William Blumentals, Mariette Boerstoel-Streefland and Ryan Ahern.?? #WorldDrugSafety #AI #RealWorldEvidence #MyCompany?

Can AI reshape the future of causality assessments in pharmacovigilance? ???? At the World Drug Safety Congress Americas 2024, Dr Siva Kumar BUDDHA ??, Director of Pharmacovigilance and Head of Signal and Risk Management at Indegene, shared his vision on leveraging AI to advance causality assessment processes. Here’s a glimpse of his insights: ?? AI-Driven Precision – Using next-gen AI tools to make causality assessments more accurate and contextually relevant. ?? Beyond Traditional Models – Addressing the limitations of static methods with advanced causal AI and knowledge graphs. ?? A New Era for Pharmacovigilance – Enabling assessments that are adaptable, explainable, and aligned with today’s safety needs. Want to learn how AI could transform pharma safety? Watch the full video to hear Dr. Buddha’s expert take on integrating AI for effective pharmacovigilance. Michael Bani #WDCA2024 #PharmaNow #Pharmacovigilance #AIInPharma #DrugSafety #InnovationInHealth #LeadershipInPharma #Indegene #FutureOfPharma